Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...
Valencia, Spain - October 29, 2024 As recovery efforts continue 20 days after the devastating DANA storm, the Bombers ...